60
Views
15
CrossRef citations to date
0
Altmetric
Paper

Time factor and treatment strategies in subclinical disease

&
Pages 495-502 | Received 30 Sep 2002, Accepted 10 Jun 2003, Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Lucyna Kepka, Krzysztof Bujko, Agnieszka Zolciak-Siwinska & Dariusz Garmol. (2008) Incidental irradiation of mediastinal and hilar lymph node stations during 3D-conformal radiotherapy for non-small cell lung cancer. Acta Oncologica 47:5, pages 954-961.
Read now
Wayne S. Kendal. (2007) Empirically-based estimates for the burden of subclinical metastases. International Journal of Radiation Biology 83:6, pages 383-393.
Read now

Articles from other publishers (13)

Erkan Topkan, Yurday Ozdemir, Ahmet Kucuk, Ali Ayberk Besen, Huseyin Mertsoylu, Ahmet Sezer & Ugur Selek. (2019) Significance of overall concurrent chemoradiotherapy duration on survival outcomes of stage IIIB/C non-small-cell lung carcinoma patients: Analysis of 956 patients. PLOS ONE 14:7, pages e0218627.
Crossref
Yi Chen, Jinyu Li, Yibao Zhang, Yi Hu, Guoqing Zhang, Xiang Yan, Zhi Lin, Zhifei Zhao & Shunchang Jiao. (2018) Early versus late prophylactic cranial irradiation in patients with extensive small cell lung cancerFrühe vs. späte prophylaktische kraniale Bestrahlung bei Patienten mit metastasiertem kleinzelligem Lungenkarzinom. Strahlentherapie und Onkologie 194:10, pages 876-885.
Crossref
Benoite Méry, Jean-Baptiste Guy, Aurélie Swalduz, Alexis Vallard, Cyril Guibert, Hweej Almokhles, Majed Ben Mrad, Romain Rivoirard, Alexander T. Falk, Pierre Fournel & Nicolas Magné. (2015) The evolving locally-advanced non-small cell lung cancer landscape: Building on past evidence and experience. Critical Reviews in Oncology/Hematology 96:2, pages 319-327.
Crossref
Bin-Liang Wang, Wei Jiang, Shi-Suo Du, Jian-Min Xu & Zhao-Chong Zeng. (2012) The Therapeutic and Adverse Effects of Modified Radiation Fields for Patients With Rectal Cancer. Clinical Colorectal Cancer 11:4, pages 255-262.
Crossref
Wayne S. Kendal. 2012. Cancer Metastasis. Cancer Metastasis 25 39 .
Beata Sas-Korczyńska, Stanisław Korzeniowski & Ewa Wójcik. (2010) Comparison of the Effectiveness of “Late” and “Early” Prophylactic Cranial Irradiation in Patients with Limited-Stage Small Cell Lung CancerVergleich der Effektivität von „später“ und „früher“ prophylaktischer Ganzhirnbestrahlung bei Patienten mit kleinzelligem Bronchialkarzinom im Limited-Disease-Stadium. Strahlentherapie und Onkologie 186:6, pages 315-319.
Crossref
Mariella Mannino & John Yarnold. (2009) Accelerated partial breast irradiation trials: Diversity in rationale and design. Radiotherapy and Oncology 91:1, pages 16-22.
Crossref
Tanguy Y Seiwert, Joseph K Salama & Everett E Vokes. (2007) The concurrent chemoradiation paradigm—general principles. Nature Clinical Practice Oncology 4:2, pages 86-100.
Crossref
Jerzy Wydmański, Rafal Suwinski, Stanislaw Poltorak, Bogusław Maka, Leszek Miszczyk, Edyta Wolny, Grzegorz Bielaczyc & Aleksander Zajusz. (2007) The tolerance and efficacy of preoperative chemoradiotherapy followed by gastrectomy in operable gastric cancer, a phase II study. Radiotherapy and Oncology 82:2, pages 132-136.
Crossref
Stephen A Roberts & Jolyon H Hendry. 2007. Radiobiological Modelling in Radiation Oncology. Radiobiological Modelling in Radiation Oncology 169 195 .
Rafal Suwinski, Jerzy Wydmanski, Iwona Pawełczyk & Jacek Starzewski. (2006) A pilot study of accelerated preoperative hyperfractionated pelvic irradiation with or without low-dose preoperative prophylactic liver irradiation in patients with locally advanced rectal cancer. Radiotherapy and Oncology 80:1, pages 27-32.
Crossref
Reinhard W. Schulte & Tianfang Li. (2016) Innovative Strategies for Image-Guided Proton Treatment of Prostate Cancer. Technology in Cancer Research & Treatment 5:2, pages 91-100.
Crossref
Alan M. Nichol, Padraig Warde & Robert G. Bristow. (2005) Optimal treatment of intermediate‐risk prostate carcinoma with radiotherapy. Cancer 104:5, pages 891-905.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.